Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 254-996-9 | CAS number: 40601-76-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982-11-29 - 1983-01-06
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was not conducted according to a current guideline. Otherwise it was a well conducted and documented study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 983
- Report date:
- 1983
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Typical procedure for micronucleus assay conducted at the time.
According to Schmid, W. The micronucleus test. Mutation Res 31: 9-15, 1975.
The test material was subjected to a micronucleus assay in mice to detect potential chromosome breaking activity according to the method of Schmid.
In the assay, 6 animals of each sex were included in each treatment group and 8 animals of each sex in the negative control group (5 animals in the treated groups and 8 animals in the control group were used for the evaluation).
Each mouse was medicated per os once daily on two consecutive days with the vehicle used for the test material (negative control), with cyclophosphamide at a concentration of 50 mg/kg bw (positive control) or with the test material at one of three dose levels (200, 1000 or 5000 mg/kg bw). The test material and the controls were administered in a standard volume of 20 ml/kg bw. This treatment schedule was selected to expose a high proportion of the cell population to the test material during two successive S-phases of the cell cycle.
24 Hours after the second treatment (48 hours after the first treatment), the mice were sacrificed and bone marrow was removed from the femora and prepared on slides for examination. One thousand polychromatic erythrocytes (PCE) as well as one thousand normochromatic erythrocytes (NCE) were scored. The ratio of PCE to NCE based on 1500 cells (PCE + NCE) counted per animal was used as a measure of the toxic efficacy of the test material. - GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1,3,5-tris[[4-tert-butyl-3-hydroxy-2,6-xylyl]methyl]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
- EC Number:
- 254-996-9
- EC Name:
- 1,3,5-tris[[4-tert-butyl-3-hydroxy-2,6-xylyl]methyl]-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
- Cas Number:
- 40601-76-1
- Molecular formula:
- C42H57N3O6
- IUPAC Name:
- tris[(4-tert-butyl-3-hydroxy-2,6-dimethylphenyl)methyl]-1,3,5-triazinane-2,4,6-trione
- Reference substance name:
- Cyanox (TM) 1790 Antioxidant
- IUPAC Name:
- Cyanox (TM) 1790 Antioxidant
- Test material form:
- solid: particulate/powder
Constituent 1
Constituent 2
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm Madoerin AG, Switzerland
- Age at study initiation: 5 weeks
- Weight at study initiation: 20-39g
- Assigned to test groups randomly: yes (using a random algorithm)
- Fasting period before study:
- Housing: housed in groups of 6 in macrolon type 3 cages with wire mesh tops and standardized granulated soft wood bedding
- Diet (e.g. ad libitum): Peletted standard Kliba 343-A mouse maintenance diet ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: 13 days - They were clinically examined by a veterinarian during this period and did not have any symptoms of disease.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 10 %
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Aqua Bidest containing 1% Tween 80
- Details on exposure:
- Mice were randomized into 3 treatment groups of 6 animals/sex (200, 1000 and 5000 mg/kg), one positive control group of 6 animals/sex (50 mg/kg cyclophosphamide) and one negative control group of 8 animals/sex [(Aqua Bidest with Tween 80(1%)]. For each dose of test material, a suspension was prepared by adding the material to Aqua Bidest containing 1% Tween 80. The suspension was homogenized and stirred with a magnetic stir bar while animals were being dosed. The test and control materials were administered by gavage once daily on two consecutive days in a volume of 20 ml/kg.
- Duration of treatment / exposure:
- 48 hours
- Frequency of treatment:
- Two treatments, one each on consecutive days
- Post exposure period:
- 24 hours after the last treatment.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- Six animals per sex per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- One positive control group of 6 animals/sex (50 mg/kg cyclophosphamide)
Examinations
- Details of tissue and slide preparation:
- Both femurs were removed from each mouse and freed of adherent tissue. Bone marrow cells were flushed out of the femurs using a needle and syringe containing 0.2 ml calf serum. Cells from both femurs were centrifuged at 1000 rpm for 5 min. Cells in the sediment were carefully mixed by aspiration in a siliconized Pasteur Pipette. A small drop of the suspension was smeared onto a slide and slides were air dried overnight. Two slides were prepared per animal. The following day, the slides were stained according to the Panoptic staining method of Pappenheim (as described in Queisser, Das Knochenmark, Georg Thieme Verlag, Stuttgart 1978, pg 12).
Slides from each animal (with the exception of 1 animal/sex from each treatment group) were blindly evaluated for the presence of micronuclei. One thousand polychromatic erythrocytes (PCE) and one thousand normochromatic erythrocytes (NCE) from each slide were screened under a microscope (at 1000x). The ratio of polychromatic to normochromatic erythrocytes based on 150 PCE and NCE per slide was calculated. The ratio of PCE/NCE was calculated and used as an index of toxicity of the test material. - Evaluation criteria:
- The test material was considered positive if the statistical T value (one-sided) was significant.
- Statistics:
- Homogeneity of test results was confirmed using the Poisson Heterogenicity test. The results of the positive control tests were not included in the analysis since they were so much higher than those of the test material. The 95% confidence limits for the L parameter of the Poisson distributions were taken from Geigy tables. Since results did not appear to be dependent on dose of the material, all doses of the material per sex were analyzed globally (compared to the negative control) using regression. The test material was considered positive if the T value (one-sided) was significant.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- One male mouse treated with 5000 mg/kg died after the second application of test material. There was no significant difference between the numbers of micronucleated polychromatic (PCE) or normochromatic erythrocytes (NCE) in treated animals versus vehicle-treated controls. The average numbers of PCE and NCE in control animals were 1.8 and 0.95, respectively. In the three groups of treated animals, the average numbers of PCE and NCE ranged from 1.2-2.0 and 0.6-1.4, respectively. There was no effect of treatment on the ratio of PCE to NCE (ranged from 0.2-2.2 in control and 0.8-2.1 in treated). The test was valid, as there was a significant increase in the number of micronucleated erythrocytes in the positive control group (23-46 micronucleated PCE/animal and 6-14 micronucleated NCE/animal in positive controls vs. 0-3 micronucleated PCE and 0-2 micronucleated NCE/animal in the negative control).
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
The test material was negative for mutagenicity in both males and females under the condition of the study. - Executive summary:
The test material was subjected to a micronucleus assay in mice to detect potential chromosome breaking activity according to the method of Schmid.
In the assay, 6 animals of each sex were included in each treatment group and 8 animals of each sex in the negative control group (5 animals in the treated groups and 8 animals in the control group were used for the evaluation).
Each mouse was medicated per gavage once daily on two consecutive days with the vehicle used for the test material (negative control), with cyclophosphamide at a concentration of 50 mg/kg bw (positive control) or with the test material at one of three dose levels (200, 1000 or 5000 mg/kg bw). The test material and the controls were administered in a standard volume of 20 ml/kg bw. This treatment schedule was selected to expose a high proportion of the cell population to the test material during two successive S-phases of the cell cycle.
24 Hours after the second treatment (48 hours after the first treatment), the mice were sacrificed and bone marrow was removed from the femora and prepared on slides for examination. One thousand polychromatic erythrocytes (PCE) as well as one thousand normochromatic erythrocytes (NCE) were scored. The ratio of PCE to NCE based on 1500 cells (PCE + NCE) counted per animal was used as a measure of the toxic efficacy of the test material.
After treatment of the mice with the test material, no substance-related increase of micronucleated erythrocytes was observed at any dose level tested in comparison with the negative control group. No toxic effects of the test material were observed. As expected, the positive controlg roup showed a significant increase in the number of micronucleated erythrocytes in comparison with the negative control group.
In conclusion, it can be stated that during this mouse micronucleus assay with the test material no chromosome-breaking activity or damage to the mitotic apparatus could be detected under the experimental conditions reported and thus no evidence of any potential chromosome mutagenic activity was demonstrable.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)